Hexamethonium Bromide in Autonomic Studies
2026-08-29
Hexamethonium Bromide provides a practical way to test how autonomic ganglia contribute to blood-pressure regulation, especially in conscious, sex-stratified hypertension models. This guide connects ganglionic blockade with telemetry, baroreflex analysis, assay controls, and troubleshooting strategies for neuronal signaling pathway research.
TUNEL Apoptosis Detection Kit: Fish Cell Workflows
2026-08-28
Build a practical TUNEL assay workflow for oxidative-stress models, tissue sections, and cultured cells using DAB-based chromogenic detection. This guide connects the miR-183-5p/Keap1-Nrf2 findings in fish cells with assay controls, optimization strategies, and troubleshooting for reproducible apoptosis research.
Carbapenemase Gene Transmission in CREC
2026-08-28
Chen et al. analyzed 54 carbapenem-resistant Enterobacter cloacae isolates from eight teaching hospitals in Guangdong, integrating gene localization, conjugation, mobile-element analysis, and clonal typing. The study shows that blaNDM-1 is frequently plasmid-associated and highly transferable, helping distinguish hospital dissemination driven by mobile genes from spread of closely related bacterial lineages.
WAY-100635 in Pain Circuit Mechanism Studies
2026-08-27
WAY-100635 is a selective 5-HT1A antagonist for testing how serotonin shapes inflammatory pain, affect, and cognition. This guide presents a causal assay framework that extends cannabidiol findings without treating receptor blockade as a therapeutic result.
Dual HER2–VEGFR2 Targeting in TNBC Metastasis
2026-08-27
The reference study tests whether lapatinib and Telatinib can jointly suppress proliferation, invadopodia formation, and angiogenic tube formation in HER2-negative MDA-MB-231 triple-negative breast cancer cells. Its main value is a phenotype-centered preclinical evaluation of dual pathway inhibition, while the in vitro design does not yet establish pharmacological synergy, target engagement, or clinical efficacy.
Demethyleneberberine: From Mechanism to Translation
2026-08-26
Demethyleneberberine (DMB) is a berberine metabolite with coordinated anti-inflammatory, antioxidant, mitochondrial, neuroprotective, and anticancer activity. This thought-leadership analysis translates its pathway biology into practical study design for inflammation, neurodegeneration, autoimmune hepatitis, ulcerative colitis, and NSCLC research while defining the evidence gaps that remain before clinical translation.
Concanamycin A: V-ATPase Workflow Guide
2026-08-26
Build a controlled workflow around Concanamycin A to connect V-ATPase inhibition with endosomal pH, apoptosis, and tumor-cell invasion. The guide combines a 20 nM, 60-minute benchmark with assay-specific controls, troubleshooting, and a cautious translation of plant secretion protocol principles into cancer biology research.
Aztreonam for Reliable Cell Assays
2026-08-25
Aztreonam (SKU A5931) supports controlled studies of Gram-negative bacterial interference, bone marrow progenitor inhibition, and hepatic cytochrome P450 effects in viability and cytotoxicity workflows. This scenario-based guide covers interpretation, solvent compatibility, dosing design, controls, and practical supplier selection.
Chenodeoxycholic Acid: Reliable FXR Assays
2026-08-25
This scenario-driven guide explains how Chenodeoxycholic Acid, SKU B1908, can help laboratories standardize FXR-focused viability, proliferation, and cytotoxicity workflows. It covers solvent compatibility, storage, protocol controls, mechanistic interpretation, and practical vendor selection using product specifications and recent FXR–KLF11 evidence.
Gepotidacin–Gyrase Mechanism in S. aureus
2026-08-24
Gibson and colleagues defined how gepotidacin inhibits Staphylococcus aureus gyrase through a mechanism distinct from fluoroquinolones, emphasizing single-stranded rather than double-stranded DNA cleavage. Biochemical assays, competition experiments, and crystal structures together identify a gyrase–DNA pocket and explain why this novel bacterial topoisomerase inhibitor may retain activity against resistant bacteria.
Neomycin Sulfate: Mechanisms and Research Uses
2026-08-23
Neomycin sulfate is an aminoglycoside antibiotic used as a mechanistic probe for RNA/DNA structure interaction studies and ion-channel research. Its documented activities include inhibition of hammerhead ribozyme cleavage, disruption of HIV-1 Tat protein and TAR RNA interaction, DNA triplex structure stabilization, and ryanodine receptor channel blockade.
DCPS and Epithelial Repair in Diabetic Foot Ulcers
2026-08-22
A 2025 World Journal of Diabetes study identifies the m7G-related decapping scavenger enzyme DCPS as a candidate biomarker and functional regulator in diabetic foot ulcers. Its integrated transcriptomic, clinical-sample, animal, and keratinocyte experiments connect reduced DCPS with impaired cell-cycle progression, proliferation, migration, and increased apoptosis.
PBS Liposomes for Rigorous Macrophage Controls
2026-08-21
PBS Liposomes provide a non-depleting comparator that separates liposome uptake and handling effects from clodronate-driven macrophage loss. This practical guide covers matched study design, workflow parameters, assay applications, and troubleshooting for more interpretable in vivo and in vitro experiments.
Isradipine (Dynacirc) for Calcium Channel Research
2026-08-20
Isradipine (Dynacirc) provides a practical way to isolate L-type calcium channel contributions in vascular, neuronal, and excitotoxicity workflows. This guide combines preparation parameters, subtype-aware assay design, and troubleshooting strategies grounded in calcium-channel pharmacology.
High Viscosity Drives P-gp Chemoresistance
2026-08-20
The reference study identifies extracellular fluid viscosity as a mechanical cue that promotes doxorubicin resistance by increasing P-glycoprotein expression through a TRPV4–YAP signaling axis. Its findings connect cytoskeletal remodeling, water influx, membrane tension, calcium signaling, and transcriptional control, providing a mechanistic framework for studying how tumor mechanics influence drug resistance.
460 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page